How Analysts Feel About Orthofix International N.V. (NASDAQ:OFIX)?

July 13, 2018 - By Benjamin Allen

Orthofix International N.V. (NASDAQ:OFIX) LogoInvestors sentiment decreased to 1.53 in 2018 Q1. Its down 0.09, from 1.62 in 2017Q4. It turned negative, as 10 investors sold Orthofix International N.V. shares while 48 reduced holdings. 32 funds opened positions while 57 raised stakes. 16.17 million shares or 2.44% less from 16.57 million shares in 2017Q4 were reported.
Diamond Hill Capital Mngmt Inc invested in 419,909 shares. Finemark Fincl Bank And Trust has 6,856 shares. Usa Financial Portformulas Corp invested in 0.02% or 1,627 shares. Moreover, Peak6 Invs Lp has 0% invested in Orthofix International N.V. (NASDAQ:OFIX). Argent Capital Management Ltd Liability has 63,480 shares. Segall Bryant And Hamill Ltd Liability Co has invested 0.9% in Orthofix International N.V. (NASDAQ:OFIX). Pura Vida Lc stated it has 0% in Orthofix International N.V. (NASDAQ:OFIX). Guggenheim Limited Com has invested 0% in Orthofix International N.V. (NASDAQ:OFIX). Quantbot Limited Partnership holds 2,753 shares. Federated Pa has 115,103 shares. Swiss Bancorp holds 0% or 31,600 shares. Strs Ohio has 0% invested in Orthofix International N.V. (NASDAQ:OFIX). Pennsylvania-based Vanguard Group Inc Inc has invested 0% in Orthofix International N.V. (NASDAQ:OFIX). Renaissance Tech Ltd Liability has invested 0.04% in Orthofix International N.V. (NASDAQ:OFIX). Macquarie Gp Limited owns 0% invested in Orthofix International N.V. (NASDAQ:OFIX) for 8,661 shares.

Since May 3, 2018, it had 1 buying transaction, and 6 sales for $5.00 million activity. 32,243 shares were sold by FUJIKAWA RAYMOND, worth $1.94 million on Wednesday, June 20. 2,500 shares valued at $144,864 were sold by Mason Brad on Thursday, June 14. 11,250 shares valued at $641,435 were sold by NIEMANN BRADLEY V. on Monday, July 2. 30,000 shares were sold by Finegan Michael, worth $1.76M on Monday, June 18. $519,724 worth of Orthofix International N.V. (NASDAQ:OFIX) was bought by MATRICARIA RONALD A.

Orthofix International N.V. (NASDAQ:OFIX) Ratings Coverage

Among 2 analysts covering Orthofix (NASDAQ:OFIX), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Orthofix had 2 analyst reports since February 27, 2018 according to SRatingsIntel. The rating was maintained by Jefferies on Tuesday, February 27 with “Buy”. Below is a list of Orthofix International N.V. (NASDAQ:OFIX) latest ratings and price target changes.

01/06/2018 Broker: Cantor Fitzgerald Rating: Overweight New Target: $62 Initiates Coverage On
27/02/2018 Broker: Jefferies Rating: Buy New Target: $68.0 Maintain

The stock decreased 1.69% or $1 during the last trading session, reaching $58.1. About 73,885 shares traded. Orthofix International N.V. (NASDAQ:OFIX) has risen 27.98% since July 13, 2017 and is uptrending. It has outperformed by 15.41% the S&P500.

Orthofix International N.V., a medical device company, provides reconstructive and regenerative orthopedic and spine solutions to physicians worldwide. The company has market cap of $1.10 billion. It operates through four divisions: BioStim, Biologics, Extremity Fixation, and Spine Fixation. It has a 78.09 P/E ratio. The BioStim segment makes, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion and are indicated as treatment to improve fusion success rates in cervical and lumbar spine, as well as a therapeutic treatment for non-spine fractures.

Another recent and important Orthofix International N.V. (NASDAQ:OFIX) news was published by Seekingalpha.com which published an article titled: “Orthofix realigns around Spine and Extremities businesses” on June 25, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.